Hefei Hanke Biotechnology

Hanke Bio is a biotechnology company specializing in the development of immunoassay kits for clinical diagnostics. The company operates in the healthcare sector, focusing on providing advanced diagnostic solutions to medical professionals and laboratories. Hanke Bio's core product line includes a range of immunoassay kits designed to deliver accurate and reliable results for various clinical conditions. The company serves hospitals, diagnostic labs, and research institutions, primarily within the Chinese market but with potential for global expansion. Hanke Bio's business model revolves around the research, development, and commercialization of its diagnostic kits. Revenue is generated through the direct sale of these kits to healthcare providers and institutions. The company has received Series A financing from two fund companies and has been recognized with several awards, including the Third Prize of the Enlightening China Anhui Innovation and Entrepreneurship Competition and the title of Young Eagle Enterprise in the High Tech Zone in 2020.

Keywords: immunoassay kits, clinical diagnostics, biotechnology, healthcare, medical professionals, diagnostic labs, research institutions, Chinese market, Series A financing, innovation awards.